PrednisoneVincristineCyclophosphamideGlucocorticoidsDoxorubicinProcarbazineAntineoplastic Combined Chemotherapy ProtocolsMechlorethaminePrednisoloneAzathioprineImmunosuppressive AgentsTreatment OutcomeMelphalanMitoxantroneDrug Therapy, CombinationAntibodies, Monoclonal, Murine-DerivedAnti-Inflammatory AgentsDrug Administration ScheduleFree RadicalsBleomycinMethotrexateColor TherapyRemission InductionChlorambucilLymphoma, Non-HodgkinCyclosporineHodgkin DiseaseLymphoma, Large B-Cell, DiffuseMycophenolic AcidFollow-Up StudiesVinblastineAdministration, OralAdrenal Cortex HormonesAsparaginaseMultiple MyelomaThalidomideTime FactorsKidney TransplantationEtoposideSurvival AnalysisRecurrenceDisease-Free SurvivalGraft RejectionTacrolimusSurvival RateMethylprednisoloneCombined Modality TherapyNephrotic Syndrome6-MercaptopurinePolymyalgia RheumaticaEtiocholanoloneProspective StudiesCyclosporinsLymphoma, FollicularClinical Trials as TopicDose-Response Relationship, DrugPrognosisVindesineCarmustineRetrospective StudiesAndrostenolsTaxoidsDouble-Blind MethodCapillary FragilityImmunosuppressionDexamethasoneBoronic AcidsLomustinePyrazinesEstramustinePrecursor Cell Lymphoblastic Leukemia-LymphomaProstatic NeoplasmsAntineoplastic Agents, HormonalRemission, SpontaneousArthritis, RheumatoidGraft SurvivalAntibodies, MonoclonalThrombocytopeniaFluoxymesterone